Laryngeal Cancer · Prevention & risk

Can laryngeal cancer be prevented?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Laryngeal Cancer Answer length: short, citable
Quick answer

Many cases are preventable. The most useful steps for laryngeal cancer are stop smoking completely — the single most effective measure, and important even after diagnosis, reduce or stop heavy alcohol use, particularly in combination with tobacco and use respiratory protection and workplace controls for asbestos, acid mist, dust and fumes. Prevention works best before exposure begins, but stopping tobacco, areca nut and heavy alcohol use still lowers risk after many years of use.

In detail

There is no population screening programme for most head and neck cancers. A routine oral examination by a dentist or doctor, plus early assessment of persistent symptoms, is currently the most practical early-detection strategy for patients outside high-risk screening programmes.

  • Stop smoking completely — the single most effective measure, and important even after diagnosis
  • Reduce or stop heavy alcohol use, particularly in combination with tobacco
  • Use respiratory protection and workplace controls for asbestos, acid mist, dust and fumes
  • Have hoarseness lasting more than 2–3 weeks assessed by an ENT specialist with laryngoscopy
  • Maintain good nutrition and manage reflux; neither substitutes for tobacco cessation

What this means in practice: this answer is part of the “Prevention & risk” section of the Laryngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about laryngeal cancer

See all 14 questions in this topic →

Sources for this answer

  1. IARC Monographs on the Identification of Carcinogenic Hazards to Humans (tobacco, areca nut, UV radiation, EBV, HPV) International Agency for Research on Cancer / WHO · 2024
  2. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  3. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  4. Nivolumab Risk Management Plan — epidemiological characteristics of SCCHN (GLOBOCAN 2022 summary) European Medicines Agency · 2025 · Reports the combined 947,211 head and neck cancer cases in 2022 and regional ASRs.
  5. Global burden and international trends in laryngeal cancer incidence (GLOBOCAN 2022 and CI5-XII) Japanese Journal of Clinical Oncology / registry-based review · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.